UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sex Differences in PPARγ Expressions in Rat Adipose Tissues

Biological and Pharmaceutical Bulletin, 2007, Vol.30(4), pp.818-820

2007

Volltextzugriff (PDF)

S8-4. Post-marketing Surveillance --From the Point of View PMDA

Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 2010, Vol.41(2), pp.51S-52S

KADOWAKI, Kyoko

2010

Volltextzugriff (PDF)

Sex differences in PPARgamma expressions in rat adipose tissues

Biological & pharmaceutical bulletin, 2007-04, Vol.30 (4), p.818-820

2007

Volltextzugriff (PDF)

S14-2. Process of Post-marketing Safety Measures --from Individual Case Safety Reports to Revisons of Precautions for Use of Pharmaceuticals

Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 2009, Vol.40(4), pp.191S-192S

KADOWAKI, Kyoko

2009

Volltextzugriff (PDF)

Sex Differences in PPAR[gamma] Expressions in Rat Adipose Tissues

Biological & pharmaceutical bulletin, 2007-04, Vol.30 (4), p.818

2007

Volltextzugriff (PDF)

Sex Differences in PPARγ Expressions in Rat Adipose Tissues

Biological & Pharmaceutical Bulletin, 2007-04, Vol.30 (4), p.818-820

2007

Volltextzugriff (PDF)

Surveillance Study about the Use Actual of the Prescription Drugs from the Viewpoint of Gender

YAKUGAKU ZASSHI, 2005/10/01, Vol.125(10), pp.821-827

2005

Volltextzugriff (PDF)

Spectrophotometric Determination of Palladium and Bismuth(III) with Semimethylxylenol Blue

Bulletin of the Chemical Society of Japan, 1983-07, Vol.56 (7), p.1968-1971

1983

Volltextzugriff (PDF)

医療機関から処方されている医薬品の男女別使用実態に関する研究

YAKUGAKU ZASSHI, 2005/10/01, Vol.125(10), pp.821-827

2005

Volltextzugriff (PDF)

Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes

Proceedings of the National Academy of Sciences - PNAS, 2012-05, Vol.109 (18), p.7049-7054

2012

Volltextzugriff (PDF)

Regeneration of CD8 alpha beta T Cells from T-cell-Derived iPSC Imparts Potent Tumor Antigen-Specific Cytotoxicity

Cancer research (Chicago, Ill.), 2016-12, Vol.76 (23), p.6839-6850

2016

Volltextzugriff (PDF)

Regeneration of CD8αβ T Cells from T-cell-Derived iPSC Imparts Potent Tumor Antigen-Specific Cytotoxicity

Cancer research (Chicago, Ill.), 2016-12, Vol.76 (23), p.6839-6850

2016

Volltextzugriff (PDF)

Efficacy of Cytotoxic Agents After Progression on Anti-PD-(L)1 Antibody for Pre-treated Metastatic Gastric Cancer

Anticancer research, 2020-04, Vol.40 (4), p.2247-2255

2020

Volltextzugriff (PDF)

Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1–ALK fusion: a case report

Investigational new drugs, 2019-08, Vol.37 (4), p.791-795

2019

Volltextzugriff (PDF)

Prevalence and associated factors of psychological distress among young adult cancer patients in Japan

Palliative & supportive care, 2023-02, Vol.21 (1), p.93-99

2023

Volltextzugriff (PDF)

Effectiveness of a facilitation programme using a mobile application for initiating advance care planning discussions between patients with advanced cancer and healthcare providers: protocol for a randomised controlled trial (J-SUPPORT 2104)

BMJ open, 2023-03, Vol.13 (3), p.e069557-e069557

2023

Volltextzugriff (PDF)

The impact of combined PD-L1 positive score on clinical response to nivolumab in patients with advanced esophageal squamous cell carcinoma

Esophagus : official journal of the Japan Esophageal Society, 2023-07, Vol.20 (3), p.524-532

2023

Volltextzugriff (PDF)

Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period

Expert opinion on pharmacotherapy, 2017-09, Vol.18 (13), p.1291-1300

2017

Volltextzugriff (PDF)

Improving patient outcomes by promoting antimicrobial stewardship for patients with positive blood cultures: Investigation of patients with gram negative bacterium

Journal of clinical pharmacy and therapeutics, 2022-10, Vol.47 (10), p.1600-1607

2022

Volltextzugriff (PDF)

High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells

Molecular therapy. Methods & clinical development, 2020-03, Vol.16, p.126-135

2020

Volltextzugriff (PDF)

Impact of omitting fluorouracil from FOLFIRI plus bevacizumab as second-line chemotherapy for patients with metastatic colorectal cancer

Journal of cancer research and clinical oncology, 2023-03, Vol.149 (3), p.1123-1129

2023

Volltextzugriff (PDF)

Impact of tumor growth rate during preceding treatment on tumor response to nivolumab or irinotecan in advanced gastric cancer

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.84-84

2019

Volltextzugriff (PDF)

MO35-4 Impact of omitting fluorouracil from FOLFIRI plus bevacizumab in second-line treatment of metastatic colorectal cancer

Annals of oncology, 2021-07, Vol.32, p.S321-S321

2021

Volltextzugriff (PDF)

MO5-4 Angiogenesis-related factors associated with nivolumab efficacy after ramucirumab therapy in advanced gastric cancer

Annals of oncology, 2021-07, Vol.32, p.S298-S298

2021

Volltextzugriff (PDF)

MO22-6 Second-line systemic therapy in patients with recurrent or metastatic adenoid cystic carcinoma

Annals of oncology, 2021-07, Vol.32, p.S312-S312

2021

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(65)
Berichte
(1)

Sprache

Englisch
(59)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(28)
Humans
(15)
Oncology
(12)
Male
(11)
Female
(9)
Animals
(8)
Middle Aged
(8)
Pharmacology & Pharmacy
(8)
Aged
(7)
Chemotherapy
(7)
Mice
(7)
Patients
(7)
Adult
(6)
Peroxisome Proliferator-Activated Receptor Γ
(6)
Medicine
(5)
Medicine, Research & Experimental
(5)
Research & Experimental Medicine
(5)
Adipose Tissue
(4)
Aged, 80 And Over
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sex Differences in PPARγ Expressions in Rat Adipose Tissues

S8-4. Post-marketing Surveillance --From the Point of View PMDA

Sex differences in PPARgamma expressions in rat adipose tissues

S14-2. Process of Post-marketing Safety Measures --from Individual Case Safety Reports to Revisons of Precautions for Use of Pharmaceuticals

Sex Differences in PPAR[gamma] Expressions in Rat Adipose Tissues

Sex Differences in PPARγ Expressions in Rat Adipose Tissues

Surveillance Study about the Use Actual of the Prescription Drugs from the Viewpoint of Gender

Spectrophotometric Determination of Palladium and Bismuth(III) with Semimethylxylenol Blue

医療機関から処方されている医薬品の男女別使用実態に関する研究

Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes

Regeneration of CD8 alpha beta T Cells from T-cell-Derived iPSC Imparts Potent Tumor Antigen-Specific Cytotoxicity

Regeneration of CD8αβ T Cells from T-cell-Derived iPSC Imparts Potent Tumor Antigen-Specific Cytotoxicity

Efficacy of Cytotoxic Agents After Progression on Anti-PD-(L)1 Antibody for Pre-treated Metastatic Gastric Cancer

Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1–ALK fusion: a case report

Prevalence and associated factors of psychological distress among young adult cancer patients in Japan

Effectiveness of a facilitation programme using a mobile application for initiating advance care planning discussions between patients with advanced cancer and healthcare providers: protocol for a randomised controlled trial (J-SUPPORT 2104)

The impact of combined PD-L1 positive score on clinical response to nivolumab in patients with advanced esophageal squamous cell carcinoma

Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period

Improving patient outcomes by promoting antimicrobial stewardship for patients with positive blood cultures: Investigation of patients with gram negative bacterium

High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells

Impact of omitting fluorouracil from FOLFIRI plus bevacizumab as second-line chemotherapy for patients with metastatic colorectal cancer

Impact of tumor growth rate during preceding treatment on tumor response to nivolumab or irinotecan in advanced gastric cancer

MO35-4 Impact of omitting fluorouracil from FOLFIRI plus bevacizumab in second-line treatment of metastatic colorectal cancer

MO5-4 Angiogenesis-related factors associated with nivolumab efficacy after ramucirumab therapy in advanced gastric cancer

MO22-6 Second-line systemic therapy in patients with recurrent or metastatic adenoid cystic carcinoma

Suchergebnisse filtern